| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/22/2004 | US6753176 Genetic engineering; antiarthritic agents |
| 06/22/2004 | US6753172 For the treatment of bacterial infection, detecting diseases related to the presence of fabi nucleic acid sequences |
| 06/22/2004 | US6753161 Optoinjection methods |
| 06/22/2004 | US6753160 Method of using metaloporphyrins for treatment of arteriosclerotic lesions |
| 06/22/2004 | US6753159 Uric acid assay device with stabilized uricase reagent composition |
| 06/22/2004 | US6753158 Drug screening for agents useful in treatment of cancers, retroviral infections, immune system disorders |
| 06/22/2004 | US6753157 Monitoring protein activity in sample; conjugate binding protein to peptide substrate, incubate with protein kinase, measure activity of kinase |
| 06/22/2004 | US6753156 Homogeneous method for detecting and/or determining phosphorylating activity in a biological material |
| 06/22/2004 | US6753155 Protein biomarker for mustard chemical injury |
| 06/22/2004 | US6753153 Markers for identification and isolation of pancreatic islet α and β progenitors |
| 06/22/2004 | US6753151 Interactions of Ku polypeptides and applications thereof |
| 06/22/2004 | US6753150 Detection of modulators of advanced glycation end product activity; obtain sample containing advanced glycation end product activity, incubate with peptide monitor adjustment in activity, adjustment in activity indicates modulator |
| 06/22/2004 | US6753148 Methods and apparatus for detecting variants utilizing base stacking |
| 06/22/2004 | US6753146 System and method for evaluating agents which prevent oxidative damage |
| 06/22/2004 | US6753143 Attaching a target analyte to a metallic surface comprising asymmetric monolayer forming species via binding to a capture binding ligand. recruitment linkers, or label probes are attached to the target analyte to form an assay complex |
| 06/22/2004 | US6753138 Use of prothymosin in the diagnosis and treatment of endometriosis |
| 06/22/2004 | US6753137 Diagnosing stomach cancer in humans; obtain fluid sample, detect epstein barr virus, the presence of the virus is an indication of stomach cancer |
| 06/22/2004 | US6753135 Determining whether a candidate drug is effective in treating a disease, by administering the drug, and measuring cd89 expression on granulocytes in the subject's sample, comparing ith standard expression |
| 06/22/2004 | US6752991 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/22/2004 | US6752964 Polymer/plasticizer based sensors |
| 06/22/2004 | US6752338 Ball mill |
| 06/22/2004 | US6752025 Hole center detecting apparatus, straightness measuring apparatus, and residual torsion measuring apparatus |
| 06/22/2004 | US6752007 Horizontal advanced tensiometer |
| 06/22/2004 | US6752001 Lubricant tester |
| 06/22/2004 | CA2360990C Hydrocarbon sensing apparatus |
| 06/22/2004 | CA2344642C Characterising polypeptides through cleavage and mass spectrometry |
| 06/22/2004 | CA2217715C Method and apparatus of testing board product |
| 06/22/2004 | CA2188635C Trace vapor detection |
| 06/22/2004 | CA2176926C .alpha.v.beta.3 integrin as a predictor of endometriosis |
| 06/22/2004 | CA2118760C Diagnosis and monitoring of colon cancer patients by measurement of nca 50/90 in blood |
| 06/22/2004 | CA2118759C Diagnosis and monitoring of lung cancer patients by measurement of nca 50/90 in blood |
| 06/22/2004 | CA2117904C Methods and reagents for diagnosis of autoantibodies |
| 06/22/2004 | CA2110702C Process for the production of a viable cell culture infected by a multiple sclerosis associated virus |
| 06/22/2004 | CA2088471C Method for determining rheumatoid factors and agents for carrying out the method |
| 06/22/2004 | CA2088404C Method for the determination of antigens or antibodies in the presence of an immune complex |
| 06/22/2004 | CA2059554C Fetal cell recovery method |
| 06/22/2004 | CA2049429C Dna sequencing |
| 06/19/2004 | CA2452946A1 Detection and diagnosis of transmissible spongiform encephalopathies |
| 06/19/2004 | CA2423904A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene |
| 06/17/2004 | WO2004052046A2 Thin membrane transducer |
| 06/17/2004 | WO2004051565A2 Optical tomography of small objects using parallel ray illumination and post-specimen optical magnification |
| 06/17/2004 | WO2004051561A2 Systems and methods for sequence comparison |
| 06/17/2004 | WO2004051281A1 Method of analyzing c-terminal amino acid sequence of peptide |
| 06/17/2004 | WO2004051280A2 Identification of agonistic autoantibodies |
| 06/17/2004 | WO2004051279A1 Method of determining site-specificity and kit therefor |
| 06/17/2004 | WO2004051278A1 Antibodies and antigens immobilised on magnetic silica particles used as biosensors |
| 06/17/2004 | WO2004051277A1 Flow-through assay devices |
| 06/17/2004 | WO2004051276A1 Magnetic particles for separating microorganisms from technical media |
| 06/17/2004 | WO2004051275A1 Method and device for transporting or binding-specific separation of electrically charged molecules |
| 06/17/2004 | WO2004051274A1 Ahemically amplified electrochemical detection of affinity reaction |
| 06/17/2004 | WO2004051273A1 Method of assaying elastin digestion product and assay kit, method of detecting aortic dissection and detection kit |
| 06/17/2004 | WO2004051271A1 Method for continuous detection of an analyte, trifunctional detecting reagent used and detecting device |
| 06/17/2004 | WO2004051270A2 Labeling methodology comprising oligopeptides |
| 06/17/2004 | WO2004051268A1 Assay for identifying antibody producing cells |
| 06/17/2004 | WO2004051266A1 Microwell array chip for detecting antigen-specific lymphocyte, method of detecting antigen-specific lymphocyte and method of cloning antigen-specific lymphocyte antigen receptor gene |
| 06/17/2004 | WO2004051264A1 Methods for measuring the activity of g(alpha)i-coupled or g(alpha)o-coupled receptors by means of the ca2+ influx in cells |
| 06/17/2004 | WO2004051263A1 Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition |
| 06/17/2004 | WO2004051262A1 Method for detecting odours |
| 06/17/2004 | WO2004051261A1 Circuit arrangement for operating a sensor comprising a heating element |
| 06/17/2004 | WO2004051254A1 Method for eddy-current testing of powdered materials |
| 06/17/2004 | WO2004051250A1 Analyzing device |
| 06/17/2004 | WO2004051249A1 Analysis instrument |
| 06/17/2004 | WO2004051248A1 Method and device for determining the water content and conductivity in the ground and in bulk materials |
| 06/17/2004 | WO2004051238A1 Device for collecting information on biological particle |
| 06/17/2004 | WO2004051233A1 Biopolymer photo-fragmenting apparatus and method of biopolymer photo-fragmentation |
| 06/17/2004 | WO2004051230A1 Fine particle handling unit, chip and sensor mounted with same, and methods for separating, capturing and sensing protein |
| 06/17/2004 | WO2004051226A2 Monitoring high-risk environments |
| 06/17/2004 | WO2004051222A2 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 06/17/2004 | WO2004051221A2 Measurement of total reactive isocyanate groups in samples using bifunctional nucleophiles such as 1,8-diaminonaphthalene (dan) |
| 06/17/2004 | WO2004051214A2 Use of fluorine nmr for high throughput screening |
| 06/17/2004 | WO2004050919A2 Surface treatment |
| 06/17/2004 | WO2004050914A1 Cancer associated plexinb1 mutations |
| 06/17/2004 | WO2004050912A2 Method and kit for ribonucleoside-specific detection and quantification |
| 06/17/2004 | WO2004050909A2 Method to measure a t cell response and its uses to qualify antigen-presenting cells |
| 06/17/2004 | WO2004050905A1 Eukaryotic biosensor making use of a calcium regulated light emitting enzyme |
| 06/17/2004 | WO2004050903A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (pde4c) |
| 06/17/2004 | WO2004050901A2 Method for the selection of cells producing specifically binding molecules |
| 06/17/2004 | WO2004050898A2 Ampk pathway components |
| 06/17/2004 | WO2004050871A1 Mixture of at least two fusion proteins, the production thereof and the use of the same |
| 06/17/2004 | WO2004050869A1 PROTEIN BINDING TO Akt2 |
| 06/17/2004 | WO2004050851A2 Prion protein ligands and methods of use |
| 06/17/2004 | WO2004050845A2 Methods of quantitation and identification of peptides and proteins |
| 06/17/2004 | WO2004050842A2 Atm kinase compositions and methods |
| 06/17/2004 | WO2004050839A2 Fragmentation-based methods and systems for sequence variation detection and discovery |
| 06/17/2004 | WO2004050837A2 Treatment of dna damage related disorders |
| 06/17/2004 | WO2004050835A2 Predicting animal performance |
| 06/17/2004 | WO2004050833A2 Glyceraldehyde 3-phosphate dehydrogenase-s(gapds), a glycolytic enzyme expressed only in male germ cells,is a target for male contraception |
| 06/17/2004 | WO2004050830A2 Methods for covalently attaching proteins to substrates |
| 06/17/2004 | WO2004050828A2 Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer |
| 06/17/2004 | WO2004050825A2 Protein synthesis monitoring (psm) |
| 06/17/2004 | WO2004050821A1 Biochemical container |
| 06/17/2004 | WO2004050706A2 Regulatory t-cells |
| 06/17/2004 | WO2004050704A1 Therapeutic and diagnostic agents |
| 06/17/2004 | WO2004050702A2 Novel ifngamma-like polypeptides |
| 06/17/2004 | WO2004050682A2 Phosphospecific pak antibodies and diagnostic kits |
| 06/17/2004 | WO2004050614A2 Flavanols and procyanidins promote homeostasis |
| 06/17/2004 | WO2004050243A1 Integrated solid-phase hydrophilic matrix circuits and micro-arrays |
| 06/17/2004 | WO2004050117A1 Proteins involved in the regulation of energy homeostasis |
| 06/17/2004 | WO2004049917A2 Methods of therapy and diagnosis using targeting of cells that express ly-9 |
| 06/17/2004 | WO2004049907A2 Compositions and methods for treating transplants |